Plain-English translation of NCT05762107 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether ZT-01, a medication you inject before bedtime, can help prevent low blood sugar episodes that happen at night in people with type 1 diabetes. The medication works by increasing the amount of a hormone called glucagon in your body when your blood sugar drops too low. Researchers want to know if this treatment can reduce how many nighttime low blood sugar episodes you experience and whether it is safe to use.
Nighttime low blood sugar is a serious and common problem for people with type 1 diabetes—it can be dangerous and scary, and it disrupts sleep. This medication is being tested because it may help your body naturally prevent these dangerous episodes from happening in the first place.
You likely qualify if…
You likely don't qualify if…
You will wear a continuous glucose monitor to track your blood sugar throughout the study. Over about 4 months, you will have two separate 4-week periods where you inject either the medication or a placebo (fake injection) before bed each night—you won't know which one you're getting. You'll continue using your own insulin and blood sugar management as usual, keep a simple evening diary, and upload your glucose data daily. You'll have about 6 study visits and 2 phone calls with the research team to check on your progress and safety.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States